Cancer Drugs Fund
Cancer52, an alliance of 90 organisations representing less common cancers, has published a briefing paper on the new Cancer Drugs Fund operating model.
It provides an overview of the key features of the new model and the current Cancer52 position on the impact it may have on access to cancer drugs in England.
